Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» spinal muscular atrophy
spinal muscular atrophy
Did Biogen Inc. Shoot Itself in the Foot?
Motley Fool
Tue, 02/21/17 - 11:11 am
Biogen
drug pricing
Spinraza
SMA
spinal muscular atrophy
Another US insurer places limits on Spinraza coverage
BioPharma Dive
Fri, 02/10/17 - 12:08 pm
Biogen
Spinraza
spinal muscular atrophy
insurers
Humana
Biogen's latest drug may be costly, but new data suggests it saves lives
Bizjournals.com
Sat, 01/14/17 - 03:37 pm
Biogen
Spinraza
SMA
spinal muscular atrophy
Is Spinraza worth $750K? Biogen says yes, spelling out reduced death risk
Endpoints
Fri, 01/13/17 - 09:41 am
Biogen
Spinraza
SMA
spinal muscular atrophy
New drug price controversy looms as Biogen stuns payers with Spinraza’s $750K sticker — analyst
Endpoints
Thu, 12/29/16 - 12:24 pm
Biogen
Spinraza
drug pricing
spinal muscular atrophy
The FDA's Christmas Breakthrough
Forbes
Tue, 12/27/16 - 10:10 am
FDA
Biogen
spinal muscular atrophy
Spinraza
Nusinersen
Poised to launch a new drug for SMA, Biogen and Ionis shares jump on more promising PhIII data
Endpoints
Mon, 11/7/16 - 09:42 am
Biogen
Ionis
spinal muscular atrophy
Nusinersen
Biogen Submits NDA for SMA Drug (BIIB, IONS)
Investopedia
Thu, 09/29/16 - 08:12 am
Biogen
SMA
spinal muscular atrophy
Ionis Pharmaceuticals
Nusinersen
Biogen, Ionis Rise as Muscle Drug Hits Goal in Late-Stage Trial
Bloomberg
Mon, 08/1/16 - 09:45 am
Biogen
Ionis
clinical trials
Nusinersen
spinal muscular atrophy
Will Ionis And Biogen Get An Early Approval For Nusinersen?
Seeking Alpha
Thu, 05/12/16 - 04:53 pm
Biogen
Ionis
Nusinersen
spinal muscular atrophy
Biogen pressed for more accessible medicines
Boston Globe, MA
Fri, 12/4/15 - 08:16 pm
Biogen
patients
spinal muscular atrophy
Infants with rare cases of SMA get stronger, live longer on Isis drug
Fierce Biotech
Thu, 06/11/15 - 10:44 am
SMA
spinal muscular atrophy
Isis Pharmaceuticals
ISIS-SMNRx
Roche presses pause on PTC's SMA drug over a safety scare
Fierce Biotech
Tue, 05/5/15 - 11:06 am
Roche
PTC Therapeutics
spinal muscular atrophy
RG7800
Pfizer backs out of development deal with Repligen
Seeking Alpha
Fri, 01/30/15 - 01:18 pm
Pfizer
Repligen
SMA
spinal muscular atrophy
Roche buys France's Trophos to expand in neuromuscular disease
Yahoo/Reuters
Fri, 01/16/15 - 07:56 am
Roche
France
Trophos
M&A
spinal muscular atrophy
Astellas adds to deal spree with expanded $675M-plus Cytokinetics pact
Fierce Biotech
Tue, 12/23/14 - 10:01 am
Astellas
Cytokinetics
CK-2127107
spinal muscular atrophy
Isis launches pivotal trial of drug for rare spine disorder
Yahoo/Reuters
Fri, 10/10/14 - 08:00 am
Isis Pharmaceuticals
ISIS-SMNRx
spinal muscular atrophy
Isis Pharma Soars on Positive Data
Yahoo/Zacks.com
Mon, 02/24/14 - 04:50 pm
Isis Pharmaceuticals
ISIS-SMNRx
spinal muscular atrophy
Isis Pharmaceuticals earns $1.5M milestone payment from Biogen Idec
The Fly on the Wall
Tue, 11/12/13 - 07:58 am
Isis Pharmaceuticals
Biogen Idec
spinal muscular atrophy
ISIS-SMNRx
Isis reaches a new high on tests for treatment of muscular disorder
Marketwatch
Fri, 09/20/13 - 09:50 am
Isis Pharmaceuticals
spinal muscular atrophy
ISIS-SMNRx
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »